TACSTD2 and breast carcinoma: In breast cancer research, selenium has been found to enhance the anticancer effect of mouse breast cancer 4T1 cells by regulating the signaling pathways of androgen receptor (AR), insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), and calcium-binding protein TROP2 [26].